Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Treatment of invasive fungal infections in intensive care units with micafungin: the MYRIADE study
Mycoses ( IF 4.1 ) Pub Date : 2020-02-25 , DOI: 10.1111/myc.13060 Jean-François Timsit 1 , Guy Leverger 2 , Noël Milpied 3 , Bertrand Gachot 4
Mycoses ( IF 4.1 ) Pub Date : 2020-02-25 , DOI: 10.1111/myc.13060 Jean-François Timsit 1 , Guy Leverger 2 , Noël Milpied 3 , Bertrand Gachot 4
Affiliation
Invasive fungal infections (IFIs) contribute significantly to nosocomial illness in intensive care units (ICUs). Current practice guidelines recommend echinocandins, such as micafungin, for the treatment of invasive candidiasis. However, limited information on their use in real‐world practice is available.
中文翻译:
米卡芬净治疗重症监护病房侵袭性真菌感染:MYRIADE 研究
侵袭性真菌感染 (IFI) 显着导致重症监护病房 (ICU) 的院内疾病。目前的实践指南推荐棘白菌素类药物,如米卡芬净,用于治疗侵袭性念珠菌病。然而,关于它们在现实世界实践中使用的信息有限。
更新日期:2020-02-25
中文翻译:
米卡芬净治疗重症监护病房侵袭性真菌感染:MYRIADE 研究
侵袭性真菌感染 (IFI) 显着导致重症监护病房 (ICU) 的院内疾病。目前的实践指南推荐棘白菌素类药物,如米卡芬净,用于治疗侵袭性念珠菌病。然而,关于它们在现实世界实践中使用的信息有限。